Authors:
BRUSAMOLINO E
ANSELMO AP
KLERSY C
SANTORO M
ORLANDI E
PAGNUCCO G
LUNGHI F
MAURIZIENRICI R
BARONI CD
LAZZARINO M
MANDELLI F
BERNASCONI C
Citation: E. Brusamolino et al., THE RISK OF ACUTE-LEUKEMIA IN PATIENTS TREATED FOR HODGKINS-DISEASE IS SIGNIFICANTLY HIGHER AFTER COMBINED-MODALITY PROGRAMS THAN AFTER CHEMOTHERAPY ALONE AND IS CORRELATED WITH THE EXTENT OF RADIOTHERAPY AND TYPE AND DURATION OF CHEMOTHERAPY - A CASE-CONTROL STUDY, Haematologica, 83(9), 1998, pp. 812-823
Authors:
BRUSAMOLINO E
ANSELMO AP
KLERSY C
SANTORO MA
ORLANDI E
PAGNUCCO G
LUNGHI F
MAURIZIENRICI R
BARONI CD
LAZZARINO M
BERNASCONI C
MANDELLI F
Citation: E. Brusamolino et al., RISK OF LEUKEMIA IN HODGKINS-DISEASE IS SIGNIFICANTLY HIGHER AFTER COMBINED-MODALITY PROGRAMS AND CORRELATES WITH THE TYPE AND DURATION OF CHEMOTHERAPY - A CASE-CONTROL STUDY, Blood, 88(10), 1996, pp. 1163-1163
Authors:
ROSSETTI C
VANOLI G
PAGANELLI G
KWIATKOWSKI M
ZITO F
COLOMBO F
BONINO C
CARPINELLI A
CASATI R
DEUTSCH K
MARMION M
WOULFE SR
LUNGHI F
DEUTSCH E
FAZIO F
Citation: C. Rossetti et al., HUMAN BIODISTRIBUTION, DOSIMETRY AND CLINICAL USE OF TECHNETIUM(III)-99M-Q12, The Journal of nuclear medicine, 35(10), 1994, pp. 1571-1580